Taxane anthracycline. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy13

Heart Tumor Cells, Cultured Cell Line, Tumor Microtubules Myocardium HL-60 Cells Myocytes, Cardiac Cell Line Mitochondria, Heart Heart Ventricles Bone Marrow Cell Nucleus Cells, Cultured

Organisms7

Taxus Streptomyces Nocardiaceae Micromonospora Nocardia Mice, Nude Bacteria

Diseases40

Breast Neoplasms Leukemia P388 Extravasation of Diagnostic and Therapeutic Materials Leukemia L1210 Neoplasm Metastasis Heart Diseases Cardiomyopathies Neoplasms Ovarian Neoplasms Leukopenia Neoplasms, Glandular and Epithelial Disease Progression Leukemia, Promyelocytic, Acute Leukemia, Myeloid, Acute Leukemia, Experimental Neutropenia Neoplasm Recurrence, Local Lung Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Nausea Peripheral Nervous System Diseases Prostatic Neoplasms Leukemia Alopecia Hematologic Diseases Adenocarcinoma Heart Failure Vomiting Carcinoma, Non-Small-Cell Lung Carcinoma, Ehrlich Tumor Recurrence Leukemia, Myeloid Lymphoma, Non-Hodgkin Carcinoma Ventricular Dysfunction, Left Lymphoma, Large B-Cell, Diffuse Hematologic Neoplasms Necrosis Carcinoma, Ductal, Breast Lymphatic Metastasis

Chemicals and Drugs88

Anthracyclines Bridged Compounds Naphthacenes Antibiotics, Antineoplastic Daunorubicin Taxoids Aclarubicin Carubicin Nogalamycin Doxorubicin Razoxane Paclitaxel Idarubicin Menogaril Epirubicin Antineoplastic Agents Epothilones Antineoplastic Agents, Phytogenic Cardiotoxins Intercalating Agents Deoxycytidine Fluorouracil Receptor, erbB-2 Ketones Vinblastine Furans Cyclophosphamide P-Glycoprotein Antibodies, Monoclonal, Humanized Glycosides Mitoxantrone DNA Topoisomerases, Type II Verapamil Cytarabine Tubulin Modulators Carboplatin Cinchona Alkaloids Cisplatin Tubulin Anthraquinones Hydrazones Bicyclo Compounds Maytansine Cardiotonic Agents Antimetabolites, Antineoplastic Receptors, Progesterone Platinum Compounds Vincristine Tumor Markers, Biological Receptors, Estrogen Mitomycin Antibodies, Monoclonal Topoisomerase II Inhibitors Diterpenes Emodin Aminoacridines Quinuclidines DNA Multidrug Resistance-Associated Proteins Free Radicals Liposomes Tumor Suppressor Protein p53 Cytochrome Reductases Antigens, Neoplasm Mitomycins Etoposide NADH Dehydrogenase Methotrexate DNA, Neoplasm Amsacrine Disaccharides Organoplatinum Compounds Macrolides Alcohol Oxidoreductases Affinity Labels Drug Carriers Antineoplastic Agents, Alkylating Neoplasm Proteins Anti-Bacterial Agents Tretinoin Polyethylene Glycols Angiogenesis Inhibitors ATP-Binding Cassette Transporters Dobutamine Quinazolines Hydrogen Peroxide Oligodeoxyribonucleotides DNA-Binding Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment55

Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Chemotherapy, Adjuvant Drug Administration Schedule Disease-Free Survival Neoadjuvant Therapy Survival Analysis Drug Screening Assays, Antitumor Infusions, Intravenous Neoplasm Staging Salvage Therapy Survival Rate Magnetic Resonance Spectroscopy Retrospective Studies Prognosis Kaplan-Meier Estimate Remission Induction Leukemia, Experimental Administration, Oral Heart Function Tests Clinical Trials as Topic Randomized Controlled Trials as Topic Prospective Studies Neoplasm Transplantation Echocardiography Drug Evaluation, Preclinical Drug Evaluation Clinical Trials, Phase III as Topic Predictive Value of Tests Chromatography, Thin Layer Echocardiography, Doppler, Pulsed Combined Modality Therapy Xenograft Model Antitumor Assays Area Under Curve Immunohistochemistry Chromatography, High Pressure Liquid Spectrophotometry, Infrared Risk Assessment Drug Carriers Follow-Up Studies Maximum Tolerated Dose Risk Factors Statistics, Nonparametric Probability Treatment Failure Multivariate Analysis Cohort Studies Stroke Volume Transplantation, Heterologous Pilot Projects Electrocardiography Proportional Hazards Models Models, Molecular Models, Chemical Patient Selection

Phenomena and Processes39

Drug Resistance, Neoplasm Dose-Response Relationship, Drug Molecular Structure Drug Resistance Drug Resistance, Multiple Physicochemical Phenomena Time Factors Cell Survival Fermentation Chemical Phenomena Ventricular Function, Left Structure-Activity Relationship Drug Synergism Apoptosis Cell Division Polymerization Gene Expression Regulation, Neoplastic Biotransformation Area Under Curve Kinetics DNA Damage Cell Proliferation Genes, erbB-2 Mitosis Maximum Tolerated Dose Oxidation-Reduction Molecular Conformation Mutation Biological Transport Diastole Probability Drug Interactions Nucleic Acid Conformation Stroke Volume Necrosis Hydrogen Bonding Systole Oxidative Stress Stereoisomerism

Disciplines and Occupations4

Chemistry, Physical Chemistry Immunohistochemistry Pharmacogenetics

Technology, Industry, Agriculture2

Liposomes Polyethylene Glycols

Information Science1

Named Groups1

Health Care24

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Retrospective Studies Kaplan-Meier Estimate Clinical Trials as Topic Randomized Controlled Trials as Topic Prospective Studies Clinical Trials, Phase III as Topic Predictive Value of Tests Area Under Curve Risk Assessment Follow-Up Studies Risk Factors Statistics, Nonparametric Probability Treatment Failure Age Factors Multivariate Analysis Cohort Studies Pilot Projects Proportional Hazards Models Patient Selection

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Named Groups Health Care

Anthracyclines Bridged Compounds Naphthacenes Antibiotics, Antineoplastic Daunorubicin Taxoids Aclarubicin Carubicin Nogalamycin Taxus Doxorubicin Razoxane Paclitaxel Idarubicin Menogaril Epirubicin Breast Neoplasms Antineoplastic Agents Epothilones Leukemia P388 Antineoplastic Combined Chemotherapy Protocols Drug Resistance, Neoplasm Antineoplastic Agents, Phytogenic Streptomyces Extravasation of Diagnostic and Therapeutic Materials Cardiotoxins Leukemia L1210 Intercalating Agents Neoplasm Metastasis Heart Diseases Treatment Outcome Chemotherapy, Adjuvant Deoxycytidine Drug Administration Schedule Fluorouracil Disease-Free Survival Receptor, erbB-2 Cardiomyopathies Ketones Neoadjuvant Therapy Vinblastine Furans Neoplasms Dose-Response Relationship, Drug Molecular Structure Cyclophosphamide Drug Resistance P-Glycoprotein Antibodies, Monoclonal, Humanized Glycosides Survival Analysis Mitoxantrone DNA Topoisomerases, Type II Ovarian Neoplasms Verapamil Heart Cytarabine Tubulin Modulators Drug Screening Assays, Antitumor Drug Resistance, Multiple Tumor Cells, Cultured Cell Line, Tumor Leukopenia Infusions, Intravenous Neoplasm Staging Carboplatin Cinchona Alkaloids Salvage Therapy Physicochemical Phenomena Cisplatin Tubulin Survival Rate Time Factors Chemistry, Physical Cell Survival Fermentation Anthraquinones Neoplasms, Glandular and Epithelial Chemistry Chemical Phenomena Magnetic Resonance Spectroscopy Disease Progression Hydrazones Leukemia, Promyelocytic, Acute Retrospective Studies Bicyclo Compounds Leukemia, Myeloid, Acute Prognosis Nocardiaceae Kaplan-Meier Estimate Micromonospora Remission Induction Maytansine Cardiotonic Agents Leukemia, Experimental Antimetabolites, Antineoplastic Ventricular Function, Left Administration, Oral Neutropenia Heart Function Tests

No FAQ available that match "taxane anthracycline"